期刊文献+

左氧氟沙星与环丙沙星治疗泌尿系感染的成本-效果分析 被引量:5

Cost-effectiveness analysis of levofloxacin and ciprofloxacin in treatment of urinary tract infection
下载PDF
导出
摘要 目的探讨左氧氟沙星与环丙沙星治疗泌尿系感染的临床疗效及经济效果。方法 86例泌尿系感染患者,按入院先后随机分为观察组与对照组各43例,观察组给予静脉滴注左氧氟沙星500mg,每天1次;对照组给予静脉滴注环丙沙星400mg,每天2次,连续给药7天为1疗程。对两组的临床疗效及医药费用进行比较分析。结果观察组的有效率为93.5%,对照组为91.3%,组间比较无显著性差异(P>0.05);观察组的总费用1292元;对照组为715元,组间比较具有显著性差异(P<0.05)。结论两种药物治疗泌尿系感染的疗效近似,但应用环丙沙星进行治疗更经济、更符合成本-效果药物经济学方案。 Objective To explore the clinical efficacy of levofloxacin and ciprofloxacin in the treatment of urinary tract infection and economic effects.Methods By order of admission,86 patients with urinary tract infection has randomly divided into observation group and control group(n=43 cases).The observation group was treated with intravenous infusion of levofloxacin 500mg,qd;control group were given intravenous ciprofloxacin 400mg,bid.Continuous administration of 7 days for a course of treatment.The clinical efficacy and cost of medicines were analyzed.Results The efficiency of the observation group was 93.5% and 91.3% in the control group.The difference was not statistically significant between groups(P0.05).The total cost of observation group was 1292 yuan while the control group was 715 yuan(P0.05).Conclusion The efficacy of two drugs is similar in the treatment of urinary tract infection,but given ciprofloxacin treatment program is more economical.
出处 《西部医学》 2012年第9期1790-1791,共2页 Medical Journal of West China
关键词 左氧氟沙星 环丙沙星 泌尿系感染 药物经济学 Levofloxacin Ciprofloxacin Urinary tract infection Pharmacoeconomics
  • 相关文献

参考文献5

二级参考文献21

共引文献26

同被引文献45

  • 1周颖杰,李光辉.成人及儿童复杂性腹腔内感染的诊断与处理:美国外科感染学会及美国感染病学会指南[J].中国感染与化疗杂志,2010,10(4):241-247. 被引量:238
  • 2黄海辉,张婴元,任振义,郑红光,俞云松,吕晓菊,肖祖克,杨惠芬,修清玉,陈宝元,岳红梅,郝青林,黄健安,马惠,肖伟,郭东阳,司彬,孙圣华,张伟,李其皓,沈华浩,段建,李华茵,姚婉贞,顾俊明,夏前明,应可净,刘翱,杨和平,施敏骅,孙铁英,丁国华,吴国明.左氧氟沙星500mg片日1次治疗下呼吸道感染和泌尿道感染的非对照、开放、多中心临床研究[J].中国感染与化疗杂志,2010,10(4):248-257. 被引量:23
  • 3Goh K L,Navaratnam P.High Helicobacter pylori resistanceto metronidazole but zero or lor resistance to clarithromycin,lev- ofloxacin,and other antibiotics in Malaysia [J].Helicobacter,2011,16(3):241-245.
  • 4Noreddin A M,Elkhatib W F.Levofloxacin in the treatment of community-acquired pneumonia [J].Expert Rev Anti Infect Ther, 2010,8(5):505-514.
  • 5Olive D,Georges H,Devos P,et al.Severe pneumococcal pneumonia:impact of new quinolones on prognosis [J].BMC Infect Dis, 2011,11(3) :66-71.
  • 6Romano M,Cuomo A,Gravina A G,et al.Empirical lev- ofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication:a randomisedtrial [J]. Gut, 2010,59( 11 ):1465-1470.
  • 7Wagenlehner F,Roscher K,Naber K G.Practice management of chronic bacterial prostatitis with levofloxacin[J].Aktuelle Urol, 2011,42(3 ):184-189.
  • 8Takahashi S, Iehihara K,Hashimoto J,et al.Clinieal efficacy of levofloxaein 500mg once daily for 7days for patients with non- gonocoecal urethritis[J].J Infect Chemother,2011,17(3):392-396.
  • 9Mitcheh A,Pangilinan F, Van der Meer J,et al. Uncoupling protein 2 polymorphisms as risk factors for NTDs[J]. Birth Defects Res A CIin Moiteratol, 2009,85 (2): 156.
  • 10胡家安,高蓓莉.左氧氟沙星静脉/口服序贯治疗老年社区获得性下呼吸道感染[J].老年医学与保健,2008,14(3):164-166. 被引量:2

引证文献5

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部